The Global Internal and External Deworming Medicine for Pets Market was valued at USD 519.30 Million in 2024 and is projected to reach USD 689.50 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 3.20% during the forecast period (2024–2032). This growth is being driven by surging pet ownership rates, heightened awareness of preventive pet healthcare, and advancements in broad-spectrum antiparasitic formulations that address both internal worms and external pests like fleas and ticks.
As the pet care industry shifts toward proactive wellness and integrated health solutions, the focus turns to pharmaceutical leaders who innovate in safe, effective deworming treatments. These companies are not just combating parasites; they are enhancing the bond between pets and owners through reliable, science-backed products. In this blog, we profile the Top 10 Companies in the Internal and External Deworming Medicine for Pets Market—a blend of multinational pharma giants, specialized veterinary firms, and innovators pioneering next-generation parasite control for dogs, cats, and beyond.
🔟 1. Zoetis Inc.
Headquarters: Parsippany, New Jersey, USA
Key Offering: Broad-spectrum dewormers like Simparica Trio, Advocate, and Revolution for internal and external parasites
Zoetis stands as a dominant force in animal health, providing comprehensive deworming solutions that target heartworms, roundworms, fleas, and ticks in one convenient dose. Their products are widely trusted by veterinarians and pet owners alike, with a strong emphasis on ease of administration and minimal side effects, serving millions of pets annually across residential and commercial settings.
Key Initiatives in Pet Health:
-
Investment in combination therapies that prevent multiple parasites simultaneously
-
Global partnerships with veterinary clinics for education on parasite prevention
-
Commitment to sustainable manufacturing practices to reduce environmental impact
Download FREE Sample Report: Internal and External Deworming Medicine for Pets Market – View in Detailed Research Report
9️⃣ 2. Boehringer Ingelheim Animal Health
Headquarters: Ingelheim, Germany
Key Offering: NexGard SPECTRA, Credelio, and Heartgard Plus for comprehensive internal and external deworming
Boehringer Ingelheim excels in delivering innovative antiparasitic treatments that protect pets from a wide array of threats, operating in over 150 countries. Their focus on research-driven formulations ensures high efficacy against resistant parasites, making them a go-to for proactive pet care routines.
Key Initiatives in Pet Health:
-
Advancements in oral chewables that combine flea, tick, and worm control
-
Collaborations with animal welfare organizations to promote regular deworming
8️⃣ 3. Merck Animal Health
Headquarters: Kenilworth, New Jersey, USA
Key Offering: Bravecto, Safe-Guard, and Panacur for targeted internal deworming and external parasite prevention
Merck Animal Health is renowned for its robust portfolio of dewormers that address everything from intestinal worms to ectoparasites, with products distributed through veterinary channels worldwide. Their commitment to science ensures treatments are both potent and pet-friendly, supporting long-term health outcomes.
Key Initiatives in Pet Health:
-
Targets for expanding access to affordable deworming in developing regions
-
Partnerships with pet food brands for bundled preventive care packages
7️⃣ 4. Elanco Animal Health
Headquarters: Greenfield, Indiana, USA
Key Offering: Credelio Quattro and Que Advantage Multi for multi-parasite protection
Elanco leads with user-friendly deworming solutions that integrate seamlessly into pet lifestyles, focusing on topical and oral options for dogs and cats. Their global reach and dedication to innovation position them as key players in reducing parasite-related health issues.
Key Initiatives in Pet Health:
-
Aim to increase R&D spending on next-gen, low-residue formulations
-
Initiatives to educate pet owners on seasonal parasite risks through digital campaigns
Download FREE Sample Report: Internal and External Deworming Medicine for Pets Market – View in Detailed Research Report
6️⃣ 5. Bayer AG Animal Health
Headquarters: Leverkusen, Germany
Key Offering: Seresto collars, Drontal, and Advantix for external and internal deworming
Bayer’s animal health division offers versatile products like long-lasting collars and tablets that combat fleas, ticks, and worms effectively. With a legacy in pharmaceuticals, they prioritize safety and efficacy, serving pet owners who seek comprehensive protection.
Key Initiatives in Pet Health:
-
Offers extended-duration protection products to minimize dosing frequency
-
Focus on eco-friendly packaging and reduced chemical runoff
5️⃣ 6. Virbac
Headquarters: Carros, France
Key Offering: Milbemax, Effitix, and Indorex for pet and home parasite control
Virbac specializes in targeted deworming therapies that are gentle on pets while aggressive on parasites, with a strong presence in Europe and expanding globally. Their solutions emphasize preventive strategies to maintain pet vitality year-round.
Key Initiatives in Pet Health:
-
Current production scaling for multi-species dewormers exceeding 500,000 units annually
-
Target to double natural ingredient-based products by 2027
4️⃣ 7. Vetoquinol
Headquarters: Lure, France
Key Offering: Pronefron, FortiFlora, and various anthelmintics for internal parasites
Vetoquinol provides specialized deworming options that support overall pet immune health, particularly for cats and dogs in high-risk environments. Their European roots and international distribution make them integral to global parasite management.
Key Initiatives in Pet Health:
-
Integration of probiotics with dewormers for better gut recovery
-
R&D programs focused on resistance management in common parasites
3️⃣ 8. Ceva Santé Animale
Headquarters: Libourne, France
Key Offering: Credelio, Program, and combination flea/tick/worm treatments
Ceva excels in affordable, accessible deworming solutions tailored for diverse pet populations, with a focus on emerging markets. Their innovative spot-on treatments and tablets help control outbreaks of external and internal parasites efficiently.
Key Initiatives in Pet Health:
-
Localized production to enhance affordability in Asia-Pacific regions
-
Collaborations with NGOs for stray animal deworming programs
2️⃣ 9. Chanelle Animal Health
Headquarters: Bury St. Edmunds, United Kingdom
Key Offering: Generic dewormers like Flevox and Beaphar Multi Wormer
Chanelle Group is a rising star in cost-effective deworming generics, offering reliable alternatives for internal and external parasites without compromising quality. Their UK-based operations ensure strict regulatory compliance and wide availability.
Key Initiatives in Pet Health:
-
Expansion of generic portfolios to cover 80% of common pet parasites
-
Major push into sustainable sourcing of active ingredients
1️⃣ 10. Norbrook Laboratories
Headquarters: Newry, Northern Ireland, UK
Key Offering: Noromectin, Synanthic, and broad-range antiparasitics
Norbrook specializes in high-volume production of deworming medicines for companion animals, emphasizing veterinary-grade purity and efficacy. They support pet health through accessible treatments that prevent severe infestations in everyday settings.
Key Initiatives in Pet Health:
-
End-to-end solutions including diagnostics and follow-up treatments
-
Strategic alliances with retailers for over-the-counter deworming access
Read Full Report: Internal and External Deworming Medicine for Pets Market – View in Detailed Research Report
🌍 Outlook: The Future of Internal and External Deworming Medicine for Pets Is Safer and More Integrated
The internal and external deworming medicine market for pets is evolving rapidly. While traditional anthelmintics remain essential, the sector is pouring resources into natural alternatives, smart delivery systems, and combination therapies that streamline care. This transition reflects broader trends in pet humanization, where owners treat animals like family members deserving of advanced health protections.
📈 Key Trends Shaping the Market:
-
Expansion of natural and organic deworming options in North America and Europe
-
Regulatory mandates for safer, residue-free formulations by 2030
-
Digital tools for parasite risk assessment and treatment reminders
-
Partnerships between pharma companies and tele-veterinary services
Market Trends Affecting the Internal and External Deworming Medicine for Pets Market
-
Consolidation among veterinary pharmaceutical giants — mergers like those involving Elanco and Bayer streamline R&D but demand vigilant monitoring of product pipelines and regional availability. Recent consolidations are optimizing global supply chains.
-
Rise of natural and plant-based ingredients — companies are shifting toward herbal extracts and probiotics to appeal to eco-conscious owners, reducing chemical reliance while meeting efficacy standards. Virbac’s natural line exemplifies this trend.
-
Integration with telemedicine and apps — mobile platforms for vet consultations and personalized deworming schedules (from Zoetis and Merck) are essential for busy pet parents managing multi-pet households.
-
Combination products for all-in-one protection — multi-action formulas tackling internal worms, fleas, and heartworms in single doses are gaining traction in compact living spaces. Boehringer leads with user-friendly innovations.
-
Growth in emerging markets and e-commerce — online sales channels and affordable generics from firms like Norbrook are driving adoption in Asia-Pacific, where pet ownership surges amid urbanization.
Read Full Report: Internal and External Deworming Medicine for Pets Market – View in Detailed Research Report
The companies highlighted here are not only protecting pets from parasites—they’re leading the charge in holistic pet wellness, ensuring healthier, happier lives for our furry companions.
Download FREE Sample Report: Internal and External Deworming Medicine for Pets Market – View in Detailed Research Report
FAQs on the Global Internal and External Deworming Medicine for Pets Market
1. What is the market size of the global internal and external deworming medicine for pets industry?
As of 2024, the global internal and external deworming medicine for pets market was valued at USD 519.30 million. It is projected to grow to USD 689.50 million by 2032, reflecting a CAGR of 3.20% during the forecast period.
2. What factors are driving the growth of the pet deworming medicine market?
The market growth is primarily driven by:
- Increasing pet ownership worldwide
- Rising awareness about pet health and parasitic infections
- Advancements in veterinary pharmaceuticals
- Government initiatives promoting pet wellness and preventive care
3. What are internal and external deworming medicines for pets?
- Internal dewormers target parasites like roundworms, hookworms, and tapeworms that live inside a pet’s digestive system.
- External dewormers help eliminate fleas, ticks, and mites that infest a pet’s skin or fur.
4. Which regions dominate the pet deworming medicine market?
North America and Europe lead the market due to high pet ownership rates and strong veterinary healthcare infrastructure. However, Asia-Pacific is witnessing the fastest growth due to increasing pet adoption and rising disposable incomes. North America was valued at USD 142.84 million in 2024, with a CAGR of 2.74% from 2025 to 2032.
5. What are the common types of pet deworming medicines available?
Deworming medicines for pets come in various forms, including:
- Liquid – Easy to mix with food for precise dosing
- Powder – Versatile for sprinkling on meals
- Tablet – Convenient chewables for quick administration
- Others – Such as topical spot-ons and collars for external use
The global Internal and External Deworming Medicine for Pets market is segmented by type into Liquid, Powder, Tablet, and Others, with applications covering Dogs, Cats, Birds, and other pets. Geographically, it spans North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.
This comprehensive view underscores the market’s potential, driven by a growing emphasis on pet preventive care. For deeper insights into segmentation, key players, and regional dynamics, the full report offers detailed analyses, including SWOT, value chain, and Porter’s Five Forces.
Industry stakeholders benefit from understanding these trends, as they inform strategies for product development, market entry, and competitive positioning. With rising pet humanization, deworming isn’t just treatment—it’s an investment in companionship.
Chapter outlines from the report highlight executive summaries, competitive landscapes, industrial chains, and quantitative forecasts, providing a roadmap for future growth. Customization options ensure tailored insights for specific needs.
In summary, as pet ownership continues to boom—projected to add millions more households worldwide—these top companies are poised to deliver innovations that keep parasites at bay and pets thriving.